Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers During AKI Varies Substantially by Treatment Facility: FR-OR007

Abstract

Peer reviewed

Benjamin R. Griffin, Masaaki Yamada, Melissa L. Swee, Diana I. Jalal and Mary Vaughan Sarrazin

Journal of the American Society of Nephrology, Vol.36(10S)

10/2025

DOI: 10.1681/ASN.2025bnp0pk2g

View Online

Title: Subtitle: Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers During AKI Varies Substantially by Treatment Facility: FR-OR007
Creators: Benjamin R. Griffin
Masaaki Yamada
Melissa L. Swee
Diana I. Jalal
Mary Vaughan Sarrazin
Resource Type: Abstract
Publication Details: Journal of the American Society of Nephrology, Vol.36(10S)
DOI: 10.1681/ASN.2025bnp0pk2g
ISSN: 1046-6673
eISSN: 1533-3450
Publisher: American Society of Nephrology
Language: English
Date published: 10/2025
Academic Unit: Health Management and Policy; Nephrology; General Internal Medicine; Internal Medicine
Record Identifier: 9985019146302771

4 Record Views